News Archives - Page 42 of 1183 - BioHealth Innovation

News

May 30, 2024

Gaithersburg’s Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch

GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc., a privately held, clinical-stage biotechnology company, announced the clearance of…

Andy

Love0

News

May 30, 2024

Linshom Medical Receives $100K MIPS award and Launches Clinical Study with Univ. of Maryland School of Medicine Faculty

BALTIMORE, MD, US, May 29, 2024 /EINPresswire.com/ -- Linshom Medical, a Maryland-based startup developing a wearable respiratory monitoring system, announced…

Andy

Love0

News

May 29, 2024

AMPEL BioSolutions Building Evidence for Prognostic Potential of Lupus Molecular Subtyping Test

NEW YORK – AMPEL BioSolutions is recruiting individuals with systemic lupus erythematosus (SLE) into an observational study of its blood-based prognostic…

Andy

Love0

News

May 29, 2024

ATCC Announces Award from NIAID to Provide Antiviral Screening Assays Relevant to Human Diseases

MANASSAS, Va.--(BUSINESS WIRE)--ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a…

Andy

Love0

News

May 29, 2024

Precision for Medicine Acquires Algorics, Enhancing Clinical Technologies and APAC Presence

The acquisition adds two proprietary clinical technologies to its portfolio and enhances Precision's global capabilities in clinical data management, biostatistics…

Andy

Love0

News

May 28, 2024

Celebrating Excellence: Maryland Tech Council 2024 ICON Award Winners

BioHealth Innovation Inc. (BHI) congratulates the outstanding winners of the 2024 ICON Awards announced by the Maryland Tech Council. These…

Andy

Love0

News

May 24, 2024

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

ROCKVILLE, Md., May 23, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…

Andy

Love0

News

May 24, 2024

Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups

RICHMOND, Va., May 23, 2024 /PRNewswire/ -- Activation Capital announces the launch of Frontier BioHealth, an educational and support program designed to…

Andy

Love0

News

May 23, 2024

ARPA-H’s NITRO selects teams to lead breakthroughs in reversing OA

Program performer teams to develop innovative ways for joints to heal themselves The Advanced Research Projects Agency for Health (ARPA-H),…

Andy

Love0

News

May 23, 2024

Rockville’s Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer

ROCKVILLE, Md., May 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed…

Andy

Love0

News

Gaithersburg’s Georgiamune Expands Cancer Treatment Pipeline with Two Novel Drugs Within Five Months of Launch

Linshom Medical Receives $100K MIPS award and Launches Clinical Study with Univ. of Maryland School of Medicine Faculty

AMPEL BioSolutions Building Evidence for Prognostic Potential of Lupus Molecular Subtyping Test

ATCC Announces Award from NIAID to Provide Antiviral Screening Assays Relevant to Human Diseases

Precision for Medicine Acquires Algorics, Enhancing Clinical Technologies and APAC Presence

Celebrating Excellence: Maryland Tech Council 2024 ICON Award Winners

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

Activation Capital Introduces ‘Frontier BioHealth’ to Catalyze Life Science Startups

ARPA-H’s NITRO selects teams to lead breakthroughs in reversing OA

Rockville’s Theriva™ Biologics Announces Fast Track Designation Granted by the U.S. FDA for VCN-01 for the Treatment of Metastatic Pancreatic Cancer

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search